The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is 42.68 USD. With the latest stock price at 163.84 USD, the upside of Repligen Corp based on DCF is -73.9%.
Based on the latest price of 163.84 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 73.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.7% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 29.43 - 81.89 | 42.68 |
| Upside | -82.0% - -50.0% | -73.9% |